Servoss Jonathan, Chang Connie, Fay Jonathan, Ward Kevin
J. Servoss is commercialization education manager, Fast Forward Medical Innovation, Medical School Office of Research, University of Michigan, Ann Arbor, Michigan.C. Chang is managing director, Fast Forward Medical Innovation, Medical School Office of Research, University of Michigan, Ann Arbor, Michigan.J. Fay is managing director, Center for Entrepreneurship, College of Engineering, University of Michigan, Ann Arbor, Michigan.K. Ward is executive director, Fast Forward Medical Innovation, Medical School Office of Research, and professor of emergency medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Acad Med. 2017 Apr;92(4):506-510. doi: 10.1097/ACM.0000000000001515.
Research produced by medical academicians holds promise for developing into biomedical innovations in therapeutics, devices, diagnostics, and health care information technology; however, the road to biomedical innovation is fraught with risk, including the challenge of moving from basic research insight onto a viable commercialization path. Compounding this challenge is the growing demand on medical academicians to be more productive in their clinical, teaching, and research duties within a resource-constrained environment.
In 2014, the University of Michigan (UM) Medical School and College of Engineering codesigned and implemented an accelerated, biomedical-focused version of the National Science Foundation (NSF) Innovation Corps (I-Corps) program. The UM Early Tech Development (ETD) Course, designed for medical academicians exploring the commercial potential of early-stage ideas, covers the NSF I-Corps concept; supports the formation of teams of faculty, graduate, and medical students; and accommodates medical academicians' schedules.
From 2014 to 2015, the ETD Course graduated 39 project teams from UM and other institutions. One-third of the teams have continued to pursue their projects, receiving additional funding, engaging industry partners, or enrolling in the NSF I-Corps program.
The ETD Course, a potential pipeline to the NSF I-Corps program, captures a target audience of medical academicians and others in academic medicine. To better understand the long-term effects of the course and its relationship to the NSF I-Corps program, the authors will conduct a study on the careers of all ETD Course graduates, including those who have enrolled in NSF I-Corps versus those who have not.
医学院士开展的研究有望发展成为治疗、设备、诊断及医疗信息技术领域的生物医学创新成果;然而,生物医学创新之路充满风险,包括从基础研究成果迈向可行商业化路径这一挑战。使这一挑战更加复杂的是,在资源有限的环境下,对医学院士在临床、教学和研究职责方面提高产出的要求日益增加。
2014年,密歇根大学医学院和工程学院共同设计并实施了一个以生物医学为重点的加速版美国国家科学基金会(NSF)创新兵团(I-Corps)项目。密歇根大学早期技术开发(ETD)课程专为探索早期想法商业潜力的医学院士设计,涵盖NSF I-Corps理念;支持组建由教师、研究生和医学生组成的团队;并适应医学院士们的日程安排。
2014年至2015年,ETD课程培养了来自密歇根大学及其他机构的39个项目团队。三分之一的团队继续推进其项目,获得了额外资金、与行业合作伙伴合作或参加了NSF I-Corps项目。
ETD课程是通往NSF I-Corps项目的潜在渠道,吸引了医学院士及学术医学领域的其他人员作为目标受众。为了更好地了解该课程的长期影响及其与NSF I-Corps项目的关系,作者将对所有ETD课程毕业生的职业发展进行研究,包括参加NSF I-Corps项目的毕业生和未参加该项目的毕业生。